Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy.

  title={Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy.},
  author={Bernhard Permanetter and W R{\"o}ssy and Gunnar Klein and F Weingartner and Karlheinz Seidl and Hans Bl{\"o}mer},
  journal={European heart journal},
  volume={13 11},
Using a placebo-controlled, double-blind cross-over study the potential therapeutic effect of ubiquinone (coenzyme Q10) was investigated in 25 patients suffering from idiopathic dilated cardiomyopathy (New York Heart Association functional classification I, II and III). Over an initial period of 4 months, 15 patients were administered verum (3 x 33.3 mg coenzyme Q10 x day-1 p.o.) and subsequently given a placebo during the ensuing 4 months (V/P). The sequence of treatment was reversed within… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 35 extracted citations

Similar Papers

Loading similar papers…